Alleviation of the Climacteric Symptoms with Oral Sequential Hormone Replacement Therapy

Journal of the Medical Association of Thailand

Volumn 87, Issue 1, 2004, Pages 1-7

  Chittacharoen, Apichart ^a   Manonai, Jittima ^a   Golbs, Siegfried ^b   Domhardt, Reiner ^b   Theppisai, Urusa ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BAYER PHARMA AG   (Germany)

Author keywords

Climacteric Symptoms; Estradiol Valerate Levonorgestrel; Hormone Replacement Therapy; Menopause

Indexed keywords

ESTRADIOL VALERATE PLUS NORGESTREL; DRUG DERIVATIVE; ESTRADIOL; LEVONORGESTREL;

ADULT; ARTICLE; ASIAN; AUTONOMIC DYSFUNCTION; CLIMACTERIUM; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENTAL DISEASE; PARAMETER; PHASE 4 CLINICAL TRIAL; POSTMENOPAUSE; PROSPECTIVE STUDY; PSYCHOLOGY; RATING SCALE; SCORING SYSTEM; SOMATOFORM DISORDER; SYMPTOM; THAILAND; DRUG COMBINATION; ESTROGEN THERAPY; METHODOLOGY; MIDDLE AGED;

CLIMACTERIC; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEVONORGESTREL; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 1542348529     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gass ML, Taylor MB. Alternatives for women through menopause. Am J Obstet Gynecol 2001; 185 (Suppl): 47-56.
2. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormonal replacement therapy and endometrial cancer risk: A meta-analysis. Obstet Gynecol 1995; 85: 304-13.
3. La Veccia C, Brinton LA, McTiernan A. Menopause, hormone replacement therapy and cancer. Maturitas 2001; 39: 97-115.
4. Goretzlehner G. The role of progestogens in hormone replacement. Drugs Today 2001; 37 (Suppl): 1-8.
5. Rozenbaum H. Progestins and endometrial safety: The French point of view. Drugs Today 1996; 32 (Suppl): 15-23.
6. Kupperman HS, Wetchler BB, Blatt MHG. Contemporary therapy of the menopausal syndrome. JAMA 1959; 171: 1627-37.
7. Hauser GA, Schneider HPG, Rosemeier HP, Potthoff P. Menopause Rating Scale II: The self-assessment scale for climacteric compllaints. J Menopause 1999; 6: 12-5.
8. Schneider HP, Heinemann LA, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): Comparison with Kupperman index and quality-of-life scale SF-36. Climacteric 2000; 3: 50-8.
9. Schneider HP, Heinemann LA, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): Reliability of scores of menopausal complaints. Climacteric 2000; 3: 59-64.
10. Schneider HP, Rosemeier HP, Schnitker J, Gerbsch S, Turck R. Application and factor analysis of the menopause rating scale (MRS) in a post-marketing surveillance study of Climen. Maturitas 2000; 37: 113-24.
11. Zimmermann T, Wisser KH, Dietrich H, Domhardt R, Chemnitius KH. Post-marketing surveillance studies of Klimonorm® in Central and Eastern Europe. Drugs Today 2001; 37 (Suppl): 19-22.
12. Nikolov R, Golbs S (Editors). Klimonorm® hormone replacement therapy in menopause. Drugs Today 2001; 37: (Suppl): 1-44
13. Rudolph I, Zimmermann T, Kaminski K, et al. Changes in psychic and somatic well-being and cognitive capabilities of peri- and postmenopausal women after the use of a hormone replacement drug containing estradiol valerate and levonorgestrel. Methods Find Exp Clin Pharmacol 2000; 22: 51-6.
14. Gräser T, Rößner P, Schubert K, Müller A, Bönisch U, Oettel M. A comparative study of two levonorgestrel-containing hormone replacement therapy regimens on efficacy and tolerability variables. Maturitas 1997; 28: 169-79.
15. Burdová K, Kancheva R, Hill M. Results of a long-term study in hormone replacement therapy with Klimonorm®. Drugs Today 2001; 37 (Suppl): 23-9.
16. Georgiev DB, Golbs S, Goudev A. Effects of the combined hormonal replacement drug estradiol valerate/levonorgestrel on climacteric complaints, endometrium and lipid profile of peri- and postmenopausal women. Meth Find Exptl Clin Pharmacol 2001; 23: 197-202.
17. Golbs S, Zimmermann H, Nikolov R, et al. The pharmacological and clinical profile of Klimonorm®. An overview. Drugs Today 2001; 37 (Suppl): 9-18.
18. Živný J, Jenícek J, Fait T, Kocian J, Vinglerová H. Changes in bone density and bone metabolism in women with surgically-induced menopause treated with a hormone replacement drug containing estradiol valerate and levonogestrel. Drugs Today 2001; 37 (Suppl): 37-44.
19. Dancsó J, Kanizsai B, Konczwald L. Effect of Klimonorm® hormone replacement therapy on urogenital complaints. In: S. Golbs, ed. Efficacy and Tolerability-HRT with Klimonorm®. Jenapharm GmbH & Co. KG, Jena, Germany, 1998: 62-8.
20. Georgiev DB. Endometrial safety during administration of the combined estrogen-progestogen hormone replacement drug Klimonorm® in perimenopausal women. Drugs Today 2001; 37 (Suppl): 31-5.